Patent · US Active

Compounds for treating cancer

US8759520B2 · kind B2 · utility

4Cited by
1References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 8, 2009
Grant dateJun 24, 2014
Priority date
Expiry dateFeb 8, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/06
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of general formula (I): wherein R1, R2, R3, R4, R5, R6, X and Y are as defined herein are inhibitors of Bcl-2 and are useful for treating diseases characterized by abnormal cell growth and/or dysregulated apoptosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.